Remimazolam Hiccups
Conditions
Interventions
Group R20:Remimazolam 0.2mg/kg was given intravenously at a rate of 20s. BIS was used to observe the sedative effect. The primary outcome measure was the incidence of hiccups within 4 minutes.
Group R40:Remimazolam 0.2mg/kg was given intravenously at a rate of 40s. BIS was used to observe the sedative effect. The primary outcome measure was the incidence of hiccups within 4 minutes.
Group R60:Remimazolam 0.2mg/kg was given intravenously at a rate of 60s. BIS was used to observe the sedative effect. The primary outcome measure was the incidence of hiccups within 4 minutes.
Sponsors
Guangzhou Women and Children's Medical Center, Guangzhou Medical University
Eligibility
Sex/Gender
All
Age
18 Years to 60 Years
Inclusion criteria
Inclusion criteria: Study population: Adult patients with ASA scores I-II who require general anesthesia in our hospital Inclusion criteria: 1. General anesthesia 2. ASA rating levels I-II 3. Age range: 18-60 years old
Exclusion criteria
Exclusion criteria: Exclusion criteria: 1. Severe cardiopulmonary dysfunction and systemic diseases 2. History of phrenic nerve injury or surgery 3. Full stomach
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| incidence of hiccups ; | — |
Countries
China
Contacts
Public ContactQianqi Qiu
Guangzhou Women and Children's Medical Center, Guangzhou Medical University
Outcome results
None listed